Seeking Alpha

Teavana (TEA -3%) responds to accusations from short seller Glaucus Research in a concise...

Teavana (TEA -3%) responds to accusations from short seller Glaucus Research in a concise statement denying them across the board. The company notes its products undergo rigorous third-party testing and calls into question the motives of the research firm.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs